Skip to main content
Premium Trial:

Request an Annual Quote

Steve Lundy, W. David Henner, David Craford

Ciphergen has named Steve Lundy senior vice president of sales and marketing, the company said this week.
 
Lundy comes to Ciphergen from GeneOhm, where he was vice president of sales and marketing. GeneOhm was acquired last year by Becton Dickinson. He had worked earlier as vice president of marketing at Esoterix and was marketing director of molecular diagnostics and critical care testing at Bayer Diagnostics.
 

 
Pathwork Diagnostics has appointed W. David Henner chief medical officer, and it has named David Craford vice president of commercial operations.
 
Henner formerly was vice president of oncology at Novacea, and Craford previously served as vice president of business development at Affymetrix.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more